185 related articles for article (PubMed ID: 25132642)
1. Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin.
Bonchak JG; Eby JM; Willenborg KA; Chrobak D; Henning SW; Krzywiec A; Johnson SL; Le Poole IC
Arch Biochem Biophys; 2014 Dec; 563():71-8. PubMed ID: 25132642
[TBL] [Abstract][Full Text] [Related]
2. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
[TBL] [Abstract][Full Text] [Related]
3. Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.
Hariharan V; Toole T; Klarquist J; Mosenson J; Longley BJ; Le Poole IC
Melanoma Res; 2011 Apr; 21(2):115-26. PubMed ID: 21317816
[TBL] [Abstract][Full Text] [Related]
4. Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.
Webb KC; Eby JM; Hariharan V; Hernandez C; Luiten RM; Le Poole IC
Exp Dermatol; 2014 Aug; 23(8):529-33. PubMed ID: 24840876
[TBL] [Abstract][Full Text] [Related]
5. Retinoic acid synergistically enhances the melanocytotoxic and depigmenting effects of monobenzylether of hydroquinone in black guinea pig skin.
Kasraee B; Fallahi MR; Ardekani GS; Ebrahimi S; Doroudchi G; Omrani GR; Handjani F; Amini M; Tanideh N; Haddadi M; Nikbakhsh M; Jahanbani S; Tran C; Sorg O; Saurat JH
Exp Dermatol; 2006 Jul; 15(7):509-14. PubMed ID: 16761959
[TBL] [Abstract][Full Text] [Related]
6. Influence of depigmenting chemical agents on hair and skin color in yellow (pheomelanic) and black (eumelanic) mice.
Quevedo WC; Holstein TJ; Dyckman J; Nordlund JJ
Pigment Cell Res; 1990; 3(2):71-9. PubMed ID: 2385568
[TBL] [Abstract][Full Text] [Related]
7. Effects of Monobenzyl ether of hydroquinone on 3T3 mouse fibroblast viability and ultrastructure.
Erdoğan A; Mutlu HS; Doğan S; Kotil T
Ultrastruct Pathol; 2021 Nov; 45(6):384-390. PubMed ID: 34875974
[TBL] [Abstract][Full Text] [Related]
8. Breaking immunological tolerance to melanocyte differentiation antigens by hypopigmenting agents: a new means for melanoma immunotherapy?
Becker JC; Schrama D
J Invest Dermatol; 2011 Jun; 131(6):1185-7. PubMed ID: 21566576
[TBL] [Abstract][Full Text] [Related]
9. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the effects of hydroquinone and arbutin on the differentiation of melanocytes.
Inoue Y; Hasegawa S; Yamada T; Date Y; Mizutani H; Nakata S; Matsunaga K; Akamatsu H
Biol Pharm Bull; 2013; 36(11):1722-30. PubMed ID: 24189417
[TBL] [Abstract][Full Text] [Related]
11. Chemical induced pathognomonic features observed in human vitiligo are mediated through miR-2909 RNomics pathway.
Kaushik H; Kaul D; Kumaran MS; Parsad D
J Dermatol Sci; 2020 Nov; 100(2):92-98. PubMed ID: 33039241
[TBL] [Abstract][Full Text] [Related]
12. Depigmentation therapies for normal skin in vitiligo universalis.
AlGhamdi KM; Kumar A
J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):749-57. PubMed ID: 21054565
[TBL] [Abstract][Full Text] [Related]
13. [Acquired leukomelanoderma caused by topical depigmenting agents].
Grojean MF; Thivolet J; Perrot H
Ann Dermatol Venereol; 1982; 109(8):641-7. PubMed ID: 7187189
[TBL] [Abstract][Full Text] [Related]
14. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents.
Dooley TP; Gadwood RC; Kilgore K; Thomasco LM
Skin Pharmacol; 1994; 7(4):188-200. PubMed ID: 8024800
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic suppression of MITF expression via HDAC inhibitors in the melanocyte lineage.
Yokoyama S; Feige E; Poling LL; Levy C; Widlund HR; Khaled M; Kung AL; Fisher DE
Pigment Cell Melanoma Res; 2008 Aug; 21(4):457-63. PubMed ID: 18627530
[TBL] [Abstract][Full Text] [Related]
16. S100B as a potential biomarker for the detection of cytotoxicity of melanocytes.
Cheong KA; Noh M; Kim CH; Lee AY
Exp Dermatol; 2014 Mar; 23(3):165-71. PubMed ID: 24451020
[TBL] [Abstract][Full Text] [Related]
17. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
Nishimaki-Mogami T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
[TBL] [Abstract][Full Text] [Related]
18. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress.
Mosenson JA; Flood K; Klarquist J; Eby JM; Koshoffer A; Boissy RE; Overbeck A; Tung RC; Le Poole IC
Pigment Cell Melanoma Res; 2014 Mar; 27(2):209-20. PubMed ID: 24354861
[TBL] [Abstract][Full Text] [Related]
19. Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature.
Mosher DB; Parrish JA; Fitzpatrick TB
Br J Dermatol; 1977 Dec; 97(6):669-79. PubMed ID: 603749
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent.
Hamed SH; Sriwiriyanont P; deLong MA; Visscher MO; Wickett RR; Boissy RE
J Cosmet Sci; 2006; 57(4):291-308. PubMed ID: 16957809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
